CN111954535A

CN111954535A - 用于编码核糖核酸的器官保护性表达和调节的组合物和方法

用于编码核糖核酸的器官保护性表达和调节的组合物和方法 Download PDF

Info

Publication number: CN111954535A
Authority: CN; China
Prior art keywords: mirna; cells; mrna; cancer; sequence
Prior art date: 2018-02-19
Legal status : Pending

Application number

CN201980013940.5A

Other languages

English (en)

Chinese (zh)

Inventor

R·米科尔

Current Assignee

United Therapeutics Corp

Original Assignee

United Therapeutics Corp

Priority date

2018-02-19

Filing date

2019-02-19

Publication date

2020-11-17

2018-09-06 Priority claimed from PCT/US2018/049772 external-priority patent/WO2019051100A1/en

2019-02-19 Application filed by United Therapeutics Corp filed Critical United Therapeutics Corp

2020-11-17 Publication of CN111954535A publication Critical patent/CN111954535A/zh

Status Pending legal-status Critical Current

Links

230000014509 gene expression Effects 0.000 title claims abstract description 113
239000000203 mixture Substances 0.000 title claims abstract description 110
238000000034 method Methods 0.000 title claims abstract description 92
229920002477 rna polymer Polymers 0.000 title description 3
230000002669 organ and tissue protective effect Effects 0.000 title description 2
239000002679 microRNA Substances 0.000 claims abstract description 109
210000000056 organ Anatomy 0.000 claims abstract description 60
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 51
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 51
229920001184 polypeptide Polymers 0.000 claims abstract description 45
108091023045 Untranslated Region Proteins 0.000 claims abstract description 38
108020004999 messenger RNA Proteins 0.000 claims abstract description 38
208000014018 liver neoplasm Diseases 0.000 claims abstract description 32
210000004185 liver Anatomy 0.000 claims abstract description 29
108091026890 Coding region Proteins 0.000 claims abstract description 25
210000004556 brain Anatomy 0.000 claims abstract description 12
210000004072 lung Anatomy 0.000 claims abstract description 12
210000000481 breast Anatomy 0.000 claims abstract description 11
208000026310 Breast neoplasm Diseases 0.000 claims abstract description 8
208000020816 lung neoplasm Diseases 0.000 claims abstract description 8
206010006187 Breast cancer Diseases 0.000 claims abstract description 7
206010061902 Pancreatic neoplasm Diseases 0.000 claims abstract description 7
208000008839 Kidney Neoplasms Diseases 0.000 claims abstract description 6
210000001072 colon Anatomy 0.000 claims abstract description 6
208000003174 Brain Neoplasms Diseases 0.000 claims abstract description 5
210000004027 cell Anatomy 0.000 claims description 350
206010028980 Neoplasm Diseases 0.000 claims description 163
108090000623 proteins and genes Proteins 0.000 claims description 137
201000011510 cancer Diseases 0.000 claims description 89
239000002245 particle Substances 0.000 claims description 71
238000002512 chemotherapy Methods 0.000 claims description 56
244000309459 oncolytic virus Species 0.000 claims description 53
102000004169 proteins and genes Human genes 0.000 claims description 50
241000700605 Viruses Species 0.000 claims description 49
230000001225 therapeutic effect Effects 0.000 claims description 47
102000040430 polynucleotide Human genes 0.000 claims description 44
108091033319 polynucleotide Proteins 0.000 claims description 44
239000002157 polynucleotide Substances 0.000 claims description 44
230000008685 targeting Effects 0.000 claims description 38
201000007270 liver cancer Diseases 0.000 claims description 34
239000003112 inhibitor Substances 0.000 claims description 31
150000007523 nucleic acids Chemical class 0.000 claims description 31
239000013598 vector Substances 0.000 claims description 30
239000003795 chemical substances by application Substances 0.000 claims description 27
102000039446 nucleic acids Human genes 0.000 claims description 22
108020004707 nucleic acids Proteins 0.000 claims description 22
239000003814 drug Substances 0.000 claims description 21
238000002560 therapeutic procedure Methods 0.000 claims description 21
-1 GP-2 Proteins 0.000 claims description 19
108700026244 Open Reading Frames Proteins 0.000 claims description 19
108010065805 Interleukin-12 Proteins 0.000 claims description 17
102000013462 Interleukin-12 Human genes 0.000 claims description 17
239000003446 ligand Substances 0.000 claims description 17
230000001018 virulence Effects 0.000 claims description 17
102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims description 16
230000002708 enhancing effect Effects 0.000 claims description 16
230000028993 immune response Effects 0.000 claims description 16
230000001413 cellular effect Effects 0.000 claims description 15
102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims description 14
229940124597 therapeutic agent Drugs 0.000 claims description 14
102000004127 Cytokines Human genes 0.000 claims description 13
108090000695 Cytokines Proteins 0.000 claims description 13
102000005962 receptors Human genes 0.000 claims description 13
108020003175 receptors Proteins 0.000 claims description 13
108010021064 CTLA-4 Antigen Proteins 0.000 claims description 12
102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 12
108010074708 B7-H1 Antigen Proteins 0.000 claims description 11
239000013603 viral vector Substances 0.000 claims description 11
101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims description 10
108010002350 Interleukin-2 Proteins 0.000 claims description 10
102000000588 Interleukin-2 Human genes 0.000 claims description 10
102100020862 Lymphocyte activation gene 3 protein Human genes 0.000 claims description 10
101100519207 Mus musculus Pdcd1 gene Proteins 0.000 claims description 10
108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims description 10
208000006359 hepatoblastoma Diseases 0.000 claims description 10
150000002632 lipids Chemical class 0.000 claims description 10
210000000496 pancreas Anatomy 0.000 claims description 10
102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 9
101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims description 9
108090001005 Interleukin-6 Proteins 0.000 claims description 9
108090001007 Interleukin-8 Proteins 0.000 claims description 9
102000004890 Interleukin-8 Human genes 0.000 claims description 9
102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 9
108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 9
239000003937 drug carrier Substances 0.000 claims description 9
206010061218 Inflammation Diseases 0.000 claims description 8
108090000174 Interleukin-10 Proteins 0.000 claims description 8
102000003814 Interleukin-10 Human genes 0.000 claims description 8
108090000978 Interleukin-4 Proteins 0.000 claims description 8
102000004388 Interleukin-4 Human genes 0.000 claims description 8
102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 8
230000002238 attenuated effect Effects 0.000 claims description 8
210000004443 dendritic cell Anatomy 0.000 claims description 8
230000004054 inflammatory process Effects 0.000 claims description 8
210000003734 kidney Anatomy 0.000 claims description 8
108091023663 let-7 stem-loop Proteins 0.000 claims description 8
108091063478 let-7-1 stem-loop Proteins 0.000 claims description 8
108091049777 let-7-2 stem-loop Proteins 0.000 claims description 8
230000001613 neoplastic effect Effects 0.000 claims description 8
239000008194 pharmaceutical composition Substances 0.000 claims description 8
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 7
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 7
239000002502 liposome Substances 0.000 claims description 7
102100024263 CD160 antigen Human genes 0.000 claims description 6
102100038078 CD276 antigen Human genes 0.000 claims description 6
108010029697 CD40 Ligand Proteins 0.000 claims description 6
101150013553 CD40 gene Proteins 0.000 claims description 6
102100032937 CD40 ligand Human genes 0.000 claims description 6
101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims description 6
101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims description 6
101000884279 Homo sapiens CD276 antigen Proteins 0.000 claims description 6
101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims description 6
101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 claims description 6
102000026633 IL6 Human genes 0.000 claims description 6
108090000177 Interleukin-11 Proteins 0.000 claims description 6
102000003815 Interleukin-11 Human genes 0.000 claims description 6
102100039064 Interleukin-3 Human genes 0.000 claims description 6
108010002616 Interleukin-5 Proteins 0.000 claims description 6
108010002586 Interleukin-7 Proteins 0.000 claims description 6
102000000585 Interleukin-9 Human genes 0.000 claims description 6
108010002335 Interleukin-9 Proteins 0.000 claims description 6
102100039390 Toll-like receptor 7 Human genes 0.000 claims description 6
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 6
239000012190 activator Substances 0.000 claims description 6
150000001720 carbohydrates Chemical class 0.000 claims description 6
235000014633 carbohydrates Nutrition 0.000 claims description 6
230000000295 complement effect Effects 0.000 claims description 6
210000005170 neoplastic cell Anatomy 0.000 claims description 6
102100036170 C-X-C motif chemokine 9 Human genes 0.000 claims description 5
206010009944 Colon cancer Diseases 0.000 claims description 5
208000001333 Colorectal Neoplasms Diseases 0.000 claims description 5
102000003886 Glycoproteins Human genes 0.000 claims description 5
108090000288 Glycoproteins Proteins 0.000 claims description 5
101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 claims description 5
241000700588 Human alphaherpesvirus 1 Species 0.000 claims description 5
206010058467 Lung neoplasm malignant Diseases 0.000 claims description 5
230000002519 immonomodulatory effect Effects 0.000 claims description 5
201000005202 lung cancer Diseases 0.000 claims description 5
150000003384 small molecules Chemical class 0.000 claims description 5
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 5
241000709698 Coxsackievirus A21 Species 0.000 claims description 4
101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims description 4
101001117312 Homo sapiens Programmed cell death 1 ligand 2 Proteins 0.000 claims description 4
239000013604 expression vector Substances 0.000 claims description 4
208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 4
230000001394 metastastic effect Effects 0.000 claims description 4
206010061289 metastatic neoplasm Diseases 0.000 claims description 4
230000035772 mutation Effects 0.000 claims description 4
201000002528 pancreatic cancer Diseases 0.000 claims description 4
208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
238000001959 radiotherapy Methods 0.000 claims description 4
241000711404 Avian avulavirus 1 Species 0.000 claims description 3
241000991587 Enterovirus C Species 0.000 claims description 3
241000712079 Measles morbillivirus Species 0.000 claims description 3
241000125945 Protoparvovirus Species 0.000 claims description 3
206010038389 Renal cancer Diseases 0.000 claims description 3
241000700584 Simplexvirus Species 0.000 claims description 3
241000711975 Vesicular stomatitis virus Species 0.000 claims description 3
238000011467 adoptive cell therapy Methods 0.000 claims description 3
238000002659 cell therapy Methods 0.000 claims description 3
210000001808 exosome Anatomy 0.000 claims description 3
201000010982 kidney cancer Diseases 0.000 claims description 3
229940126586 small molecule drug Drugs 0.000 claims description 3
241000701161 unidentified adenovirus Species 0.000 claims description 3
201000003076 Angiosarcoma Diseases 0.000 claims description 2
238000011357 CAR T-cell therapy Methods 0.000 claims description 2
208000001258 Hemangiosarcoma Diseases 0.000 claims description 2
229940076838 Immune checkpoint inhibitor Drugs 0.000 claims description 2
230000003044 adaptive effect Effects 0.000 claims description 2
208000006990 cholangiocarcinoma Diseases 0.000 claims description 2
239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims description 2
108091070501 miRNA Proteins 0.000 claims 10
101100510617 Caenorhabditis elegans sel-8 gene Proteins 0.000 claims 3
102000013816 Cytotoxic T-lymphocyte antigen 4 Human genes 0.000 claims 3
102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 3
102000003945 NF-kappa B Human genes 0.000 claims 3
108010057466 NF-kappa B Proteins 0.000 claims 3
102000002689 Toll-like receptor Human genes 0.000 claims 3
108020000411 Toll-like receptor Proteins 0.000 claims 3
241000700618 Vaccinia virus Species 0.000 claims 1
HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 claims 1
231100000331 toxic Toxicity 0.000 claims 1
230000002588 toxic effect Effects 0.000 claims 1
108700011259 MicroRNAs Proteins 0.000 abstract description 101
238000011282 treatment Methods 0.000 abstract description 16
201000010099 disease Diseases 0.000 abstract description 13
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
208000029742 colonic neoplasm Diseases 0.000 abstract description 3
210000001519 tissue Anatomy 0.000 description 69
108091032973 (ribonucleotides)n+m Proteins 0.000 description 51
238000001890 transfection Methods 0.000 description 50
210000001744 T-lymphocyte Anatomy 0.000 description 48
235000018102 proteins Nutrition 0.000 description 44
239000000047 product Substances 0.000 description 35
210000003494 hepatocyte Anatomy 0.000 description 33
230000000694 effects Effects 0.000 description 31
108020004414 DNA Proteins 0.000 description 28
206010073071 hepatocellular carcinoma Diseases 0.000 description 25
239000013612 plasmid Substances 0.000 description 24
239000002105 nanoparticle Substances 0.000 description 23
238000000338 in vitro Methods 0.000 description 22
239000000427 antigen Substances 0.000 description 18
108091007433 antigens Proteins 0.000 description 18
102000036639 antigens Human genes 0.000 description 18
108020004705 Codon Proteins 0.000 description 17
210000002865 immune cell Anatomy 0.000 description 17
125000003729 nucleotide group Chemical group 0.000 description 17
108020005345 3' Untranslated Regions Proteins 0.000 description 16
239000002773 nucleotide Substances 0.000 description 16
230000001105 regulatory effect Effects 0.000 description 16
230000014616 translation Effects 0.000 description 16
241001465754 Metazoa Species 0.000 description 15
238000013519 translation Methods 0.000 description 15
238000002474 experimental method Methods 0.000 description 14
231100000844 hepatocellular carcinoma Toxicity 0.000 description 14
230000008569 process Effects 0.000 description 14
108091007780 MiR-122 Proteins 0.000 description 13
150000001875 compounds Chemical class 0.000 description 13
239000000243 solution Substances 0.000 description 13
230000003612 virological effect Effects 0.000 description 13
241000699666 Mus <mouse, genus> Species 0.000 description 12
238000009472 formulation Methods 0.000 description 12
238000001727 in vivo Methods 0.000 description 12
239000002609 medium Substances 0.000 description 12
239000000126 substance Substances 0.000 description 12
108091008874 T cell receptors Proteins 0.000 description 11
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 11
230000006870 function Effects 0.000 description 11
230000001965 increasing effect Effects 0.000 description 11
230000002829 reductive effect Effects 0.000 description 11
241000699670 Mus sp. Species 0.000 description 10
238000004519 manufacturing process Methods 0.000 description 10
239000002953 phosphate buffered saline Substances 0.000 description 10
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 10
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 9
102000008203 CTLA-4 Antigen Human genes 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 9
230000003834 intracellular effect Effects 0.000 description 9
108091051828 miR-122 stem-loop Proteins 0.000 description 9
238000011002 quantification Methods 0.000 description 9
230000009467 reduction Effects 0.000 description 9
239000003981 vehicle Substances 0.000 description 9
108010019670 Chimeric Antigen Receptors Proteins 0.000 description 8
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 8
108091028043 Nucleic acid sequence Proteins 0.000 description 8
230000006907 apoptotic process Effects 0.000 description 8
230000008901 benefit Effects 0.000 description 8
230000006378 damage Effects 0.000 description 8
230000037361 pathway Effects 0.000 description 8
238000003752 polymerase chain reaction Methods 0.000 description 8
230000010076 replication Effects 0.000 description 8
238000003786 synthesis reaction Methods 0.000 description 8
210000004881 tumor cell Anatomy 0.000 description 8
230000006044 T cell activation Effects 0.000 description 7
238000013459 approach Methods 0.000 description 7
210000003719 b-lymphocyte Anatomy 0.000 description 7
230000000139 costimulatory effect Effects 0.000 description 7
238000005516 engineering process Methods 0.000 description 7
238000000799 fluorescence microscopy Methods 0.000 description 7
238000013518 transcription Methods 0.000 description 7
230000035897 transcription Effects 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
102100038080 B-cell receptor CD22 Human genes 0.000 description 6
102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 6
102000019034 Chemokines Human genes 0.000 description 6
108010012236 Chemokines Proteins 0.000 description 6
108010035532 Collagen Proteins 0.000 description 6
102000008186 Collagen Human genes 0.000 description 6
101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 6
101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 6
210000000612 antigen-presenting cell Anatomy 0.000 description 6
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
238000010367 cloning Methods 0.000 description 6
229920001436 collagen Polymers 0.000 description 6
239000005547 deoxyribonucleotide Substances 0.000 description 6
125000002637 deoxyribonucleotide group Chemical group 0.000 description 6
238000005538 encapsulation Methods 0.000 description 6
239000003623 enhancer Substances 0.000 description 6
239000012634 fragment Substances 0.000 description 6
230000002068 genetic effect Effects 0.000 description 6
238000003384 imaging method Methods 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
230000000670 limiting effect Effects 0.000 description 6
230000036210 malignancy Effects 0.000 description 6
210000004789 organ system Anatomy 0.000 description 6
229920000136 polysorbate Polymers 0.000 description 6
230000035755 proliferation Effects 0.000 description 6
230000004044 response Effects 0.000 description 6
230000035899 viability Effects 0.000 description 6
230000007923 virulence factor Effects 0.000 description 6
239000000304 virulence factor Substances 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
241000282412 Homo Species 0.000 description 5
108010001336 Horseradish Peroxidase Proteins 0.000 description 5
229930182555 Penicillin Natural products 0.000 description 5
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
230000000947 anti-immunosuppressive effect Effects 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
238000003776 cleavage reaction Methods 0.000 description 5
230000009089 cytolysis Effects 0.000 description 5
238000011161 development Methods 0.000 description 5
230000018109 developmental process Effects 0.000 description 5
230000003828 downregulation Effects 0.000 description 5
238000009169 immunotherapy Methods 0.000 description 5
230000001976 improved effect Effects 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
230000009437 off-target effect Effects 0.000 description 5
229940049954 penicillin Drugs 0.000 description 5
229920000642 polymer Polymers 0.000 description 5
238000011160 research Methods 0.000 description 5
230000007017 scission Effects 0.000 description 5
229960005322 streptomycin Drugs 0.000 description 5
238000012546 transfer Methods 0.000 description 5
230000004614 tumor growth Effects 0.000 description 5
108020003589 5' Untranslated Regions Proteins 0.000 description 4
208000023275 Autoimmune disease Diseases 0.000 description 4
108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 4
108010010803 Gelatin Proteins 0.000 description 4
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
241000725303 Human immunodeficiency virus Species 0.000 description 4
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 4
102000007330 LDL Lipoproteins Human genes 0.000 description 4
108010007622 LDL Lipoproteins Proteins 0.000 description 4
206010027476 Metastases Diseases 0.000 description 4
101710163270 Nuclease Proteins 0.000 description 4
102000003992 Peroxidases Human genes 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
101710089372 Programmed cell death protein 1 Proteins 0.000 description 4
108091028664 Ribonucleotide Proteins 0.000 description 4
108010041388 Ribonucleotide Reductases Proteins 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
238000010171 animal model Methods 0.000 description 4
239000005557 antagonist Substances 0.000 description 4
230000000840 anti-viral effect Effects 0.000 description 4
238000002648 combination therapy Methods 0.000 description 4
230000004927 fusion Effects 0.000 description 4
229920000159 gelatin Polymers 0.000 description 4
239000008273 gelatin Substances 0.000 description 4
235000019322 gelatine Nutrition 0.000 description 4
235000011852 gelatine desserts Nutrition 0.000 description 4
238000001415 gene therapy Methods 0.000 description 4
230000036541 health Effects 0.000 description 4
QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 4
239000007788 liquid Substances 0.000 description 4
210000005228 liver tissue Anatomy 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
230000005012 migration Effects 0.000 description 4
238000013508 migration Methods 0.000 description 4
238000010172 mouse model Methods 0.000 description 4
231100000252 nontoxic Toxicity 0.000 description 4
230000003000 nontoxic effect Effects 0.000 description 4
238000005457 optimization Methods 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
108040007629 peroxidase activity proteins Proteins 0.000 description 4
150000003904 phospholipids Chemical class 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
230000003362 replicative effect Effects 0.000 description 4
108091008146 restriction endonucleases Proteins 0.000 description 4
238000012552 review Methods 0.000 description 4
239000002336 ribonucleotide Substances 0.000 description 4
125000002652 ribonucleotide group Chemical group 0.000 description 4
230000004083 survival effect Effects 0.000 description 4
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
FAWLNURBQMTKEB-URDPEVQOSA-N 213546-53-3 Chemical compound N([C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1[C@@H](CCC1)C(O)=O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C FAWLNURBQMTKEB-URDPEVQOSA-N 0.000 description 3
208000005623 Carcinogenesis Diseases 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
239000007995 HEPES buffer Substances 0.000 description 3
101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 description 3
101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 3
101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 description 3
108090000144 Human Proteins Proteins 0.000 description 3
102000003839 Human Proteins Human genes 0.000 description 3
108091058560 IL8 Proteins 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
102100020881 Interleukin-1 alpha Human genes 0.000 description 3
102000000743 Interleukin-5 Human genes 0.000 description 3
102000004889 Interleukin-6 Human genes 0.000 description 3
102000000704 Interleukin-7 Human genes 0.000 description 3
206010025323 Lymphomas Diseases 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
206010057249 Phagocytosis Diseases 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
102000000505 Ribonucleotide Reductases Human genes 0.000 description 3
108010060818 Toll-Like Receptor 9 Proteins 0.000 description 3
102100033117 Toll-like receptor 9 Human genes 0.000 description 3
102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 description 3
108010003533 Viral Envelope Proteins Proteins 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
125000000539 amino acid group Chemical group 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
230000006023 anti-tumor response Effects 0.000 description 3
239000012298 atmosphere Substances 0.000 description 3
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
230000036952 cancer formation Effects 0.000 description 3
229910002091 carbon monoxide Inorganic materials 0.000 description 3
231100000504 carcinogenesis Toxicity 0.000 description 3
230000005754 cellular signaling Effects 0.000 description 3
235000012000 cholesterol Nutrition 0.000 description 3
238000010276 construction Methods 0.000 description 3
210000004748 cultured cell Anatomy 0.000 description 3
230000001472 cytotoxic effect Effects 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
238000010586 diagram Methods 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
229940079593 drug Drugs 0.000 description 3
230000012202 endocytosis Effects 0.000 description 3
238000002073 fluorescence micrograph Methods 0.000 description 3
108091006047 fluorescent proteins Proteins 0.000 description 3
102000034287 fluorescent proteins Human genes 0.000 description 3
239000000499 gel Substances 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
239000012642 immune effector Substances 0.000 description 3
230000002163 immunogen Effects 0.000 description 3
229940121354 immunomodulator Drugs 0.000 description 3
238000011065 in-situ storage Methods 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
230000003902 lesion Effects 0.000 description 3
208000032839 leukemia Diseases 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
230000009401 metastasis Effects 0.000 description 3
239000000693 micelle Substances 0.000 description 3
238000002156 mixing Methods 0.000 description 3
210000000822 natural killer cell Anatomy 0.000 description 3
230000017128 negative regulation of NF-kappaB transcription factor activity Effects 0.000 description 3
230000000174 oncolytic effect Effects 0.000 description 3
230000007170 pathology Effects 0.000 description 3
230000008782 phagocytosis Effects 0.000 description 3
229940002612 prodrug Drugs 0.000 description 3
239000000651 prodrug Substances 0.000 description 3
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 3
239000002356 single layer Substances 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
241000894007 species Species 0.000 description 3
238000010186 staining Methods 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
230000009885 systemic effect Effects 0.000 description 3
210000003462 vein Anatomy 0.000 description 3
230000029812 viral genome replication Effects 0.000 description 3
238000001262 western blot Methods 0.000 description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
108010082078 3-Phosphoinositide-Dependent Protein Kinases Proteins 0.000 description 2
102100037263 3-phosphoinositide-dependent protein kinase 1 Human genes 0.000 description 2
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 2
108091023037 Aptamer Proteins 0.000 description 2
208000025324 B-cell acute lymphoblastic leukemia Diseases 0.000 description 2
102100036848 C-C motif chemokine 20 Human genes 0.000 description 2
102100021942 C-C motif chemokine 28 Human genes 0.000 description 2
102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 2
101100463133 Caenorhabditis elegans pdl-1 gene Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
206010008342 Cervix carcinoma Diseases 0.000 description 2
229920002101 Chitin Polymers 0.000 description 2
229920001661 Chitosan Polymers 0.000 description 2
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
239000006145 Eagle's minimal essential medium Substances 0.000 description 2
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 2
101710091045 Envelope protein Proteins 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
108091093094 Glycol nucleic acid Proteins 0.000 description 2
206010019695 Hepatic neoplasm Diseases 0.000 description 2
101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 2
101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 description 2
101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 2
101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 2
101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 2
101500025562 Homo sapiens Saposin-A Proteins 0.000 description 2
101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 2
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
101100195053 Human herpesvirus 1 (strain 17) RIR1 gene Proteins 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
108091008036 Immune checkpoint proteins Proteins 0.000 description 2
102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
238000012404 In vitro experiment Methods 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
102000000589 Interleukin-1 Human genes 0.000 description 2
108050003558 Interleukin-17 Proteins 0.000 description 2
102000013691 Interleukin-17 Human genes 0.000 description 2
102000017761 Interleukin-33 Human genes 0.000 description 2
108010067003 Interleukin-33 Proteins 0.000 description 2
102100026236 Interleukin-8 Human genes 0.000 description 2
108010076876 Keratins Proteins 0.000 description 2
102000011782 Keratins Human genes 0.000 description 2
102100035304 Lymphotactin Human genes 0.000 description 2
241001372913 Maraba virus Species 0.000 description 2
108700019961 Neoplasm Genes Proteins 0.000 description 2
102000048850 Neoplasm Genes Human genes 0.000 description 2
206010029260 Neuroblastoma Diseases 0.000 description 2
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
206010033128 Ovarian cancer Diseases 0.000 description 2
206010061535 Ovarian neoplasm Diseases 0.000 description 2
229930040373 Paraformaldehyde Natural products 0.000 description 2
108091093037 Peptide nucleic acid Proteins 0.000 description 2
229920002873 Polyethylenimine Polymers 0.000 description 2
101710188315 Protein X Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
108010032838 Sialoglycoproteins Proteins 0.000 description 2
102000007365 Sialoglycoproteins Human genes 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
208000005718 Stomach Neoplasms Diseases 0.000 description 2
102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
108091036066 Three prime untranslated region Proteins 0.000 description 2
108091046915 Threose nucleic acid Proteins 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
102000004338 Transferrin Human genes 0.000 description 2
108090000901 Transferrin Proteins 0.000 description 2
101710090322 Truncated surface protein Proteins 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
238000012382 advanced drug delivery Methods 0.000 description 2
230000000735 allogeneic effect Effects 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
230000005975 antitumor immune response Effects 0.000 description 2
238000003782 apoptosis assay Methods 0.000 description 2
238000003556 assay Methods 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
239000002775 capsule Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
230000032823 cell division Effects 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
230000003833 cell viability Effects 0.000 description 2
201000010881 cervical cancer Diseases 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
230000002301 combined effect Effects 0.000 description 2
239000000470 constituent Substances 0.000 description 2
206010052015 cytokine release syndrome Diseases 0.000 description 2
230000005860 defense response to virus Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
229940124447 delivery agent Drugs 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
229960003957 dexamethasone Drugs 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
230000008482 dysregulation Effects 0.000 description 2
239000012636 effector Substances 0.000 description 2
230000017188 evasion or tolerance of host immune response Effects 0.000 description 2
230000003176 fibrotic effect Effects 0.000 description 2
238000010362 genome editing Methods 0.000 description 2
208000005017 glioblastoma Diseases 0.000 description 2
239000008103 glucose Substances 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
208000024908 graft versus host disease Diseases 0.000 description 2
230000005931 immune cell recruitment Effects 0.000 description 2
230000008629 immune suppression Effects 0.000 description 2
238000003119 immunoblot Methods 0.000 description 2
230000000415 inactivating effect Effects 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
244000144972 livestock Species 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
108010082117 matrigel Proteins 0.000 description 2
239000012528 membrane Substances 0.000 description 2
210000003071 memory t lymphocyte Anatomy 0.000 description 2
239000011859 microparticle Substances 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
229920002866 paraformaldehyde Polymers 0.000 description 2
210000001539 phagocyte Anatomy 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
238000011176 pooling Methods 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
239000002243 precursor Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000005522 programmed cell death Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
230000002633 protecting effect Effects 0.000 description 2
RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
238000010814 radioimmunoprecipitation assay Methods 0.000 description 2
108010054624 red fluorescent protein Proteins 0.000 description 2
230000008844 regulatory mechanism Effects 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
208000011571 secondary malignant neoplasm Diseases 0.000 description 2
238000013207 serial dilution Methods 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
238000012353 t test Methods 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
239000008399 tap water Substances 0.000 description 2
235000020679 tap water Nutrition 0.000 description 2
150000003512 tertiary amines Chemical class 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
239000012581 transferrin Substances 0.000 description 2
230000009466 transformation Effects 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
OGHAROSJZRTIOK-KQYNXXCUSA-O 7-methylguanosine Chemical compound C1=2N=C(N)NC(=O)C=2[N+](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-O 0.000 description 1
102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
241001316595 Acris Species 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
102000002572 Alpha-Globulins Human genes 0.000 description 1
108010068307 Alpha-Globulins Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
108010031480 Artificial Receptors Proteins 0.000 description 1
208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
230000003844 B-cell-activation Effects 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241001416152 Bos frontalis Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
238000009010 Bradford assay Methods 0.000 description 1
102100025277 C-X-C motif chemokine 13 Human genes 0.000 description 1
102100032912 CD44 antigen Human genes 0.000 description 1
229940045513 CTLA4 antagonist Drugs 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
208000017897 Carcinoma of esophagus Diseases 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
206010057248 Cell death Diseases 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
239000005751 Copper oxide Substances 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
238000007399 DNA isolation Methods 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
208000002699 Digestive System Neoplasms Diseases 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
241000463291 Elga Species 0.000 description 1
102100030013 Endoribonuclease Human genes 0.000 description 1
101710199605 Endoribonuclease Proteins 0.000 description 1
102000013128 Endothelin B Receptor Human genes 0.000 description 1
108010090557 Endothelin B Receptor Proteins 0.000 description 1
102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 1
108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
208000000461 Esophageal Neoplasms Diseases 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 1
108090000331 Firefly luciferases Proteins 0.000 description 1
238000011770 Fox Chase SCID mouse Methods 0.000 description 1
206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
208000031448 Genomic Instability Diseases 0.000 description 1
101001070329 Geobacillus stearothermophilus 50S ribosomal protein L18 Proteins 0.000 description 1
108010061711 Gliadin Proteins 0.000 description 1
201000010915 Glioblastoma multiforme Diseases 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
208000009329 Graft vs Host Disease Diseases 0.000 description 1
101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 description 1
101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 description 1
101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 1
101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 description 1
108010042653 IgA receptor Proteins 0.000 description 1
102000037982 Immune checkpoint proteins Human genes 0.000 description 1
102000037978 Immune checkpoint receptors Human genes 0.000 description 1
108091008028 Immune checkpoint receptors Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
108020005350 Initiator Codon Proteins 0.000 description 1
102100022339 Integrin alpha-L Human genes 0.000 description 1
102100037850 Interferon gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000003812 Interleukin-15 Human genes 0.000 description 1
108090000172 Interleukin-15 Proteins 0.000 description 1
102100030703 Interleukin-22 Human genes 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
101710094902 Legumin Proteins 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
238000000719 MTS assay Methods 0.000 description 1
231100000070 MTS assay Toxicity 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
206010027457 Metastases to liver Diseases 0.000 description 1
102000014171 Milk Proteins Human genes 0.000 description 1
108010011756 Milk Proteins Proteins 0.000 description 1
101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
102100037589 OX-2 membrane glycoprotein Human genes 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000009328 Perro Species 0.000 description 1
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
241000288906 Primates Species 0.000 description 1
108091000054 Prion Proteins 0.000 description 1
102000029797 Prion Human genes 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
241000700159 Rattus Species 0.000 description 1
208000015634 Rectal Neoplasms Diseases 0.000 description 1
241000702263 Reovirus sp. Species 0.000 description 1
201000000582 Retinoblastoma Diseases 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
108010047827 Sialic Acid Binding Immunoglobulin-like Lectins Proteins 0.000 description 1
102000007073 Sialic Acid Binding Immunoglobulin-like Lectins Human genes 0.000 description 1
208000000453 Skin Neoplasms Diseases 0.000 description 1
108010073771 Soybean Proteins Proteins 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
101710196623 Stimulator of interferon genes protein Proteins 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
206010066901 Treatment failure Diseases 0.000 description 1
108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
101150044878 US18 gene Proteins 0.000 description 1
102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
206010047139 Vasoconstriction Diseases 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
229920002494 Zein Polymers 0.000 description 1
108010055615 Zein Proteins 0.000 description 1
YIJVOACVHQZMKI-JXOAFFINSA-N [[(2r,3s,4r,5r)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 YIJVOACVHQZMKI-JXOAFFINSA-N 0.000 description 1
VEWJOCYCKIZKKV-GBNDHIKLSA-N [[(2r,3s,4r,5s)-5-(2,4-dioxo-1h-pyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1C1=CNC(=O)NC1=O VEWJOCYCKIZKKV-GBNDHIKLSA-N 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
206010000496 acne Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
208000009956 adenocarcinoma Diseases 0.000 description 1
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
230000000676 anti-immunogenic effect Effects 0.000 description 1
230000001028 anti-proliverative effect Effects 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
238000011394 anticancer treatment Methods 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
229960003852 atezolizumab Drugs 0.000 description 1
230000006472 autoimmune response Effects 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
239000003124 biologic agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000008236 biological pathway Effects 0.000 description 1
230000008512 biological response Effects 0.000 description 1
230000029918 bioluminescence Effects 0.000 description 1
238000005415 bioluminescence Methods 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
210000004958 brain cell Anatomy 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
230000021164 cell adhesion Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
230000008614 cellular interaction Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229940044683 chemotherapy drug Drugs 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
HGCIXCUEYOPUTN-UHFFFAOYSA-N cis-cyclohexene Natural products C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
230000008045 co-localization Effects 0.000 description 1
229940075614 colloidal silicon dioxide Drugs 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000007398 colorimetric assay Methods 0.000 description 1
238000011284 combination treatment Methods 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229910000431 copper oxide Inorganic materials 0.000 description 1
108091008034 costimulatory receptors Proteins 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000006196 deacetylation Effects 0.000 description 1
238000003381 deacetylation reaction Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000008260 defense mechanism Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000010432 diamond Substances 0.000 description 1
206010012818 diffuse large B-cell lymphoma Diseases 0.000 description 1
AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000002296 dynamic light scattering Methods 0.000 description 1
230000002900 effect on cell Effects 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000007368 endocrine function Effects 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000001723 extracellular space Anatomy 0.000 description 1
235000013861 fat-free Nutrition 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
230000007614 genetic variation Effects 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
230000003862 health status Effects 0.000 description 1
238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
238000007489 histopathology method Methods 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
230000007440 host cell apoptosis Effects 0.000 description 1
230000007438 host cellular process Effects 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
229940051026 immunotoxin Drugs 0.000 description 1
230000002637 immunotoxin Effects 0.000 description 1
239000002596 immunotoxin Substances 0.000 description 1
231100000608 immunotoxin Toxicity 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000012606 in vitro cell culture Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
108091008042 inhibitory receptors Proteins 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
108010074108 interleukin-21 Proteins 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
229960005386 ipilimumab Drugs 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
239000002523 lectin Substances 0.000 description 1
210000005162 left hepatic lobe Anatomy 0.000 description 1
108091091807 let-7a stem-loop Proteins 0.000 description 1
108091057746 let-7a-4 stem-loop Proteins 0.000 description 1
108091028376 let-7a-5 stem-loop Proteins 0.000 description 1
108091024393 let-7a-6 stem-loop Proteins 0.000 description 1
108091091174 let-7a-7 stem-loop Proteins 0.000 description 1
108091007423 let-7b Proteins 0.000 description 1
108091028973 let-7k stem-loop Proteins 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
235000020778 linoleic acid Nutrition 0.000 description 1
230000029226 lipidation Effects 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
230000004807 localization Effects 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
210000003519 mature b lymphocyte Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000036630 mental development Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002736 metal compounds Chemical class 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
108091044988 miR-125a stem-loop Proteins 0.000 description 1
108091049513 miR-125a-1 stem-loop Proteins 0.000 description 1
108091040046 miR-125a-2 stem-loop Proteins 0.000 description 1
238000001000 micrograph Methods 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
235000021239 milk protein Nutrition 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
238000001565 modulated differential scanning calorimetry Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
230000004660 morphological change Effects 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
210000004985 myeloid-derived suppressor cell Anatomy 0.000 description 1
239000002539 nanocarrier Substances 0.000 description 1
239000013642 negative control Substances 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
229960003301 nivolumab Drugs 0.000 description 1
108091027963 non-coding RNA Proteins 0.000 description 1
102000042567 non-coding RNA Human genes 0.000 description 1
210000004967 non-hematopoietic stem cell Anatomy 0.000 description 1
208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
230000025308 nuclear transport Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
238000012379 oncolytic virotherapy Methods 0.000 description 1
244000045947 parasite Species 0.000 description 1
238000005192 partition Methods 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229960002621 pembrolizumab Drugs 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000007030 peptide scission Effects 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
210000004180 plasmocyte Anatomy 0.000 description 1
210000002706 plastid Anatomy 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
230000032029 positive regulation of DNA repair Effects 0.000 description 1
230000007859 posttranscriptional regulation of gene expression Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000000751 protein extraction Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
230000005588 protonation Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
229950010131 puromycin Drugs 0.000 description 1
230000003439 radiotherapeutic effect Effects 0.000 description 1
230000010837 receptor-mediated endocytosis Effects 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
230000009712 regulation of translation Effects 0.000 description 1
210000005084 renal tissue Anatomy 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
230000002784 sclerotic effect Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
QYHFIVBSNOWOCQ-UHFFFAOYSA-N selenic acid Chemical compound O[Se](O)(=O)=O QYHFIVBSNOWOCQ-UHFFFAOYSA-N 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
235000002639 sodium chloride Nutrition 0.000 description 1
RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
229940001941 soy protein Drugs 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
230000002966 stenotic effect Effects 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
201000011549 stomach cancer Diseases 0.000 description 1
201000000498 stomach carcinoma Diseases 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
238000002626 targeted therapy Methods 0.000 description 1
238000011191 terminal modification Methods 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
229940124788 therapeutic inhibitor Drugs 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000009752 translational inhibition Effects 0.000 description 1
229950007217 tremelimumab Drugs 0.000 description 1
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
230000025033 vasoconstriction Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
230000007502 viral entry Effects 0.000 description 1
230000007733 viral latency Effects 0.000 description 1
238000000316 virotherapy Methods 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000009736 wetting Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000008096 xylene Substances 0.000 description 1
239000005019 zein Substances 0.000 description 1
229940093612 zein Drugs 0.000 description 1